Electroacupuncture regulates microglia polarization via lncRNA-mediated hippo pathway after ischemic stroke

Shenxu Chen1,2, Linmei Wang1, Ying Yuan1,3

  • 1Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Insights

Electroacupuncture (EA) reduces brain inflammation after ischemic stroke by regulating microglia polarization. This study identifies Lnc826 and the Hippo pathway as key targets for EA

Area of Science:

  • Neuroscience
  • Inflammation Research
  • Traditional Chinese Medicine

Background:

  • Microglia polarization and inflammation are critical in ischemic brain injury.
  • Electroacupuncture (EA) is a validated anti-inflammatory treatment for ischemic stroke.
  • The precise mechanism of EA's anti-inflammatory effect in ischemic brain injury is unclear.

Purpose of the Study:

  • To investigate the anti-inflammatory mechanism of EA in a rat model of ischemic brain injury.
  • To identify key molecular pathways and long non-coding RNAs (lncRNAs) involved in EA's therapeutic effects.

Main Methods:

  • Middle cerebral artery occlusion (MCAA) rat model and in vitro oxygen-glucose deprivation (OGD) model.
  • Analysis of microglia activation and inflammatory cytokines.
  • Whole-transcriptome sequencing to identify differentially expressed lncRNAs.
  • Bioinformatic analysis including Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
  • Validation of specific lncRNA (TCONS_00022826/Lnc826) function in microglia polarization.

Main Results:

  • EA treatment significantly reduced microglia activation and inflammatory cytokine levels in MCAO rats.
  • Whole-transcriptome sequencing identified 44 differentially expressed lncRNAs, implicating the Hippo pathway.
  • LncRNA Lnc826 was upregulated in MCAO and downregulated by EA, promoting M1 microglia polarization via the Hippo pathway.

Conclusions:

  • EA exerts anti-inflammatory effects in ischemic brain injury by modulating microglia polarization.
  • The Lnc826-mediated Hippo pathway is a potential molecular mechanism underlying EA's therapeutic action.
  • Targeting Lnc826 and the Hippo pathway offers a novel therapeutic strategy for ischemic stroke.

Related Concept Videos